SEC Form 4 · accession 0001140361-16-068315
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J Williams Ph.D.
Officer — Executive Vice President
Period of report
Jun 1, 2016
Accepted (ET)
Jun 2, 2016 · 5:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2016 | M | 2,598 | $0.00 | A | 42,696 | D | |
| Common Stock | Jun 1, 2016 | F | 805 | $88.18 | D | 41,891 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF3,F2 | — | Jun 1, 2016 | M | 2,598 | D | — | — | Common Stock | 2,598 | 11,267 | D |
Explanation of responses
- F1Includes 87 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2016.
- F2Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five equal annual installments, beginning June 1, 2012 and has been adjusted to reflect the the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015.
- F3Not applicable.